N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142180 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142181 |
| CAS No | NA |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142182 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142184 |
| CAS No | NA |
| Mol.F. | C17H14BrClFN5O4 |
| Mol.Wt. | 486.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142183 |
| CAS No | 51715-17-4 |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142185 |
| CAS No | NA |
| Mol.F. | C15H9BrClFN4O3 |
| Mol.Wt. | 427.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142186 |
| CAS No | NA |
| Mol.F. | C21H22BrClFN5O4 |
| Mol.Wt. | 542.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142187 |
| CAS No | NA |
| Mol.F. | C17H14Cl2FN5O4 |
| Mol.Wt. | 442.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142188 |
| CAS No | NA |
| Mol.F. | C16H12BrClFN5O4 |
| Mol.Wt. | 472.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142189 |
| CAS No | NA |
| Mol.F. | C17H19N3OS |
| Mol.Wt. | 313.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142190 |
| CAS No | NA |
| Mol.F. | C12H8N2OS |
| Mol.Wt. | 228.27g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142191 |
| CAS No | NA |
| Mol.F. | C17H19N3O2S |
| Mol.Wt. | 329.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142192 |
| CAS No | NA |
| Mol.F. | C29H26N4OS2 |
| Mol.Wt. | 510.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142193 |
| CAS No | NA |
| Mol.F. | C56H77N17O13 |
| Mol.Wt. | 1196.34 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142194 |
| CAS No | NA |
| Mol.F. | C10H12N4OS |
| Mol.Wt. | 236.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142195 |
| CAS No | NA |
| Mol.F. | C12H14N4O4S |
| Mol.Wt. | 310.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |